Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

ACELYRIN Inc

SLRN
4,2214
-0,1386 (-3,18%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/6/202423:05EDGAR2Form 8-K - Current report
05/6/202413:00GLOBEACELYRIN, INC. Announces Positive 16-week Data From its..
29/5/202413:00GLOBEACELYRIN, INC. Announces Lonigutamab Phase 1/2..
28/5/202423:20EDGAR2Form 8-K/A - Current report: [Amend]
25/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/5/202401:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202401:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/5/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:14EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/5/202414:13EDGAR2Form 8-K - Current report
09/5/202414:01GLOBEACELYRIN, INC. Provides Business Update and Highlights Key..
09/5/202414:00GLOBEACELYRIN, INC. Announces Leadership Transition
29/4/202422:05GLOBEACELYRIN, INC. to Report First Quarter 2024 Financial..
28/3/202421:05GLOBEACELYRIN, INC. Reports Full Year 2023 Financial Results and..
27/3/202421:01GLOBEAvalo Acquires Anti-IL-1β mAb and Announces Private..
20/3/202412:00GLOBEACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept..
11/3/202413:05EDGAR2Form 8-K - Current report
11/3/202413:02GLOBEACELYRIN, INC. Announces Positive Top-line Results from Its..
11/3/202413:00GLOBEACELYRIN, INC. Announces Long-term 32-Week Data from the..
15/2/202422:05GLOBEACELYRIN, INC. Appoints Agnes Lee as Senior Vice President,..
12/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/1/202400:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/1/202400:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202411:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
20/12/202322:38EDGAR2Form 8-K - Current report
20/12/202322:30GLOBEACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors
18/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/12/202314:00PRNUSDiCello Levitt LLP Announces Investor Class Action Lawsuit..
04/12/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202312:03IHMARKETNEWSTuesday’s Wall Street Highlights: Zscaler, Shein, 3M, Meta..
28/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27/11/202322:31EDGAR2Form 8-K - Current report
27/11/202322:30GLOBEACELYRIN, INC. Provides Update on Izokibep Clinical..
21/11/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/11/202322:23EDGAR2Form 8-K - Current report
07/11/202322:05GLOBEACELYRIN, INC. Reports Third Quarter 2023 Financial Results..
06/11/202313:00GLOBEACELYRIN, INC. Appoints Patricia Turney as Chief Technical..
31/10/202321:30GLOBEACELYRIN, INC. to Report Third Quarter 2023 Financial..
06/10/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202313:00GLOBEACELYRIN, INC. Scales for Continued Late-Stage Growth with..
12/9/202315:23IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
12/9/202313:29IHMARKETNEWSTuesday’s Wall Street Highlights: Apple, Acelyrin, WestRock,..
12/9/202302:03DJNStocks to Watch: Oracle, Acelyrin, Humacyte
11/9/202322:05GLOBEACELYRIN, INC. Announces Top-Line Results from..
06/9/202313:00GLOBEACELYRIN, INC. to Present at the Morgan Stanley 21st Annual..
21/8/202322:03EDGAR2Form 8-K - Current report
19/8/202300:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 4,30 Min: 4,145 Max: 4,4989
Chiusura: 4,36

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network